IndraLab

Statements

USP19 inhibits Hypertrophy. 1 / 1

| 1

reach

"The USP19 attenuates pathological cardiac hypertrophy by inhibiting the TAK1-dependent pathway (Miao et al. 2020), and in addition, Tang et al. found that USP7 reduces myocardial ischemia-reperfusion injury by regulating ferroptosis (Tang et al. 2021), suggesting an important role for the presence of USP in the heart."

37953295

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

USP19 inhibits Hypertrophy. 1 / 1

INDRA sources:

Databases

Reading